+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioconjugation Market by Bioconjugation Type (Oligonucleotide Bioconjugation, Peptide Bioconjugation, Polymer Bioconjugation), Offering (Antibody Drug Conjugates, Linkers, Reagents & Kits), Technique, Type, End User, Applications - Global Forecast 2025-2030- Product Image
Bioconjugation Market by Bioconjugation Type (Oligonucleotide Bioconjugation, Peptide Bioconjugation, Polymer Bioconjugation), Offering (Antibody Drug Conjugates, Linkers, Reagents & Kits), Technique, Type, End User, Applications - Global Forecast 2025-2030- Product Image
Sale

Bioconjugation Market by Bioconjugation Type (Oligonucleotide Bioconjugation, Peptide Bioconjugation, Polymer Bioconjugation), Offering (Antibody Drug Conjugates, Linkers, Reagents & Kits), Technique, Type, End User, Applications - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083776
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers in life sciences face accelerating complexity and competition in the bioconjugation market. As scientific and technological innovation drive new strategies and applications, the sector’s evolution directly impacts partner selection, investment priorities, and operational resilience for organizations across biopharmaceutical, research, and contract service domains.

Market Snapshot: Bioconjugation Market Growth and Trends

The bioconjugation market grew from USD 5.40 billion in 2024 to USD 6.04 billion in 2025. It is anticipated to sustain a CAGR of 12.35%, with revenues reaching USD 10.87 billion by 2030. The expansion reflects increased demand for advanced conjugation solutions in therapeutics, diagnostics, and research. Drivers include the adoption of modular manufacturing approaches, increased regulatory engagement, and the emergence of cross-sector alliances that streamline innovation and commercialization.

Scope & Segmentation: Comprehensive Analysis of the Bioconjugation Landscape

This report delivers an in-depth examination of market structure, technology adoption, application scope, and regional performance. Detailed segmentation covers product, end-user, and geographic factors relevant to bioconjugation initiatives worldwide.

  • Bioconjugation Types: Oligonucleotide bioconjugation (including double-stranded and single-stranded molecules), peptide bioconjugation, polymer bioconjugation, and protein bioconjugation.
  • Offering Categories: Antibody drug conjugates, linkers, reagents and kits, services such as ADC process development, and drug substance manufacturing.
  • Core Techniques: Amide bond formation, click chemistry, and thiol-maleimide coupling methods utilized to enable diverse payload attachment, stability, and purification.
  • Molecular Origin: Natural bioconjugates and synthetic bioconjugates, each with distinct production, reproducibility, and regulatory characteristics.
  • Key End Users: Academic and research institutions, biotechnology companies, contract research organizations, and pharmaceutical companies with distinct application drivers.
  • Major Applications: Diagnostics, research and development, and therapeutics, encompassing antibiotics, monoclonal antibodies, and vaccines.
  • Regional Coverage: Americas (including specific U.S. states and leading markets in Canada, Mexico, Brazil, and Argentina), Europe, Middle East & Africa (spanning Western and Eastern Europe, MENA countries, and emerging markets), and Asia-Pacific (China, India, Japan, Australia, and Southeast Asia).
  • Company Coverage: Profiles and trend analysis for leading industry participants, including AbbVie Inc., AstraZeneca PLC, Pfizer Inc., Thermo Fisher Scientific Inc., Lonza Group AG, and others.

Key Takeaways: Strategic Insights for Leadership

  • Continuous innovation in linking chemistries and conjugation workflows is enabling greater selectivity and scalability across platforms.
  • High-throughput screening and process digitalization support real-time analytics, reducing variability and enhancing confidence with regulatory agencies.
  • Strong cross-sector collaborations facilitate collective problem-solving, accelerating the pace of technology adoption and solution co-creation.
  • Supply chain and sourcing strategies are being revisited in response to evolving tariff and trade environments, emphasizing the importance of resilient procurement models.
  • Regional differences in infrastructure, regulatory frameworks, and funding significantly impact the speed and breadth of market adoption for bioconjugation products and services.
  • Platform diversification and integrated service models are becoming central in securing sustained competitive advantage.

Tariff Impact: Navigating Changing Trade Policies

Recent United States tariff measures have increased the cost and complexity of sourcing key raw materials, reagents, and specialty components for bioconjugation. Organizations are adjusting procurement strategies, building on-shore inventories, diversifying suppliers, and prioritizing domestic production capabilities to maintain continuity and protect margins under shifting trade conditions.

Methodology & Data Sources

This analysis is underpinned by rigorous research methods, including secondary data from peer-reviewed literature, patents, regulatory documents, and conference proceedings. Primary insights were gained through interviews with senior leaders in R&D, process development, and regulatory affairs. Expert triangulation validates data integrity, ensuring a fact-based approach throughout the report.

Why This Report Matters

  • Enables strategic alignment of R&D investments by providing nuanced understanding of segment growth drivers, partnership opportunities, and technology adoptions.
  • Supports proactive decision-making regarding supply chain resilience, regulatory compliance, and new market entry strategies.
  • Equips leadership with actionable competitive intelligence on emerging best practices and innovation patterns shaping the bioconjugation sector.

Conclusion

Bioconjugation is progressing rapidly, with innovation, regulation, and trade shaping market opportunities and risks. This report equips senior executives to anticipate trends, strengthen operations, and engage confidently in a dynamic global landscape.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Application of bioorthogonal conjugation techniques for real-time imaging in live-cell diagnostics
5.2. Development of novel enzymatic ligation strategies for controlled protein-drug conjugation in targeted therapies
5.3. Integration of site-specific click chemistry methods to enhance ADC homogeneity and efficacy
5.4. Adoption of strain-promoted alkyne-azide cycloaddition in vivo for non-invasive targeted drug delivery studies
5.5. Development of ultrastable maleimide derivatives minimizing premature payload release in systemic circulation
5.6. Implementation of dual-function linkers combining imaging and therapeutic payload delivery in theranostic agents
5.7. Scalable microfluidic platforms for high-throughput screening of bioconjugation reaction parameters
5.8. Use of glycan-engineered antibodies for site-selective conjugation to improve therapeutic index
5.9. Advanced click-to-release chemistries facilitating on-demand drug activation at tumor sites
5.10. Emergence of PEG-free linkers enabling reduced immunogenicity in antibody-drug conjugates
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioconjugation Market, by Bioconjugation Type
8.1. Introduction
8.2. Oligonucleotide Bioconjugation
8.2.1. Double-Stranded Oligonucleotides
8.2.2. Single-Stranded Oligonucleotides
8.3. Peptide Bioconjugation
8.4. Polymer Bioconjugation
8.5. Protein Bioconjugation
9. Bioconjugation Market, by Offering
9.1. Introduction
9.2. Antibody Drug Conjugates
9.3. Linkers
9.4. Reagents & Kits
9.5. Services
9.5.1. ADC Process Development
9.5.2. Drug Substance Manufacturing
10. Bioconjugation Market, by Technique
10.1. Introduction
10.2. Amide Bond Formation
10.3. Click Chemistry
10.4. Thiol-Maleimide Coupling
11. Bioconjugation Market, by Type
11.1. Introduction
11.2. Natural Bioconjugates
11.3. Synthetic Bioconjugates
12. Bioconjugation Market, by End User
12.1. Introduction
12.2. Academic & Research Institutions
12.3. Biotechnology Companies
12.4. Contract Research Organizations
12.5. Pharmaceutical Companies
13. Bioconjugation Market, by Applications
13.1. Introduction
13.2. Diagnostics
13.3. Research & Development
13.4. Therapeutics
13.4.1. Antibiotics
13.4.2. Monoclonal Antibodies
13.4.3. Vaccines
14. Americas Bioconjugation Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Bioconjugation Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Bioconjugation Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. AbbVie Inc.
17.3.2. Abcam plc by Danaher Corporation
17.3.3. Abzena Limited
17.3.4. Agilent Technologies, Inc.
17.3.5. Amgen Inc.
17.3.6. AstraZeneca PLC
17.3.7. Bio-Techne Corporation
17.3.8. Biocon Limited
17.3.9. Boehringer Ingelheim GmbH
17.3.10. Bristol-Myers Squibb Company
17.3.11. Charles River Laboratories International, Inc.
17.3.12. Eli Lilly and Company
17.3.13. F. Hoffmann-La Roche AG
17.3.14. GlaxoSmithKline plc
17.3.15. Innovagen AB
17.3.16. Johnson & Johnson Services Inc
17.3.17. Lonza Group AG
17.3.18. Merck KGaA
17.3.19. Pfizer Inc.
17.3.20. Sanofi S.A.
17.3.21. Sartorius AG
17.3.22. Sorrento Therapeutics, Inc.
17.3.23. Sutro Biopharma, Inc.
17.3.24. Thermo Fisher Scientific Inc.
17.3.25. WuXi AppTec Co., Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOCONJUGATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOCONJUGATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOCONJUGATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOCONJUGATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOCONJUGATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOCONJUGATION MARKET: RESEARCHAI
FIGURE 28. BIOCONJUGATION MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOCONJUGATION MARKET: RESEARCHCONTACTS
FIGURE 30. BIOCONJUGATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOCONJUGATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOCONJUGATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOCONJUGATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOCONJUGATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOCONJUGATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOCONJUGATION MARKET SIZE, BY DOUBLE-STRANDED OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOCONJUGATION MARKET SIZE, BY DOUBLE-STRANDED OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOCONJUGATION MARKET SIZE, BY SINGLE-STRANDED OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOCONJUGATION MARKET SIZE, BY SINGLE-STRANDED OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOCONJUGATION MARKET SIZE, BY PEPTIDE BIOCONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOCONJUGATION MARKET SIZE, BY PEPTIDE BIOCONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOCONJUGATION MARKET SIZE, BY POLYMER BIOCONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOCONJUGATION MARKET SIZE, BY POLYMER BIOCONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOCONJUGATION MARKET SIZE, BY PROTEIN BIOCONJUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOCONJUGATION MARKET SIZE, BY PROTEIN BIOCONJUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOCONJUGATION MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOCONJUGATION MARKET SIZE, BY ANTIBODY DRUG CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOCONJUGATION MARKET SIZE, BY LINKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOCONJUGATION MARKET SIZE, BY LINKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOCONJUGATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOCONJUGATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOCONJUGATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOCONJUGATION MARKET SIZE, BY SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOCONJUGATION MARKET SIZE, BY ADC PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOCONJUGATION MARKET SIZE, BY ADC PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOCONJUGATION MARKET SIZE, BY DRUG SUBSTANCE MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOCONJUGATION MARKET SIZE, BY DRUG SUBSTANCE MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOCONJUGATION MARKET SIZE, BY AMIDE BOND FORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOCONJUGATION MARKET SIZE, BY AMIDE BOND FORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOCONJUGATION MARKET SIZE, BY CLICK CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOCONJUGATION MARKET SIZE, BY CLICK CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOCONJUGATION MARKET SIZE, BY THIOL-MALEIMIDE COUPLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOCONJUGATION MARKET SIZE, BY THIOL-MALEIMIDE COUPLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOCONJUGATION MARKET SIZE, BY NATURAL BIOCONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOCONJUGATION MARKET SIZE, BY NATURAL BIOCONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOCONJUGATION MARKET SIZE, BY SYNTHETIC BIOCONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOCONJUGATION MARKET SIZE, BY SYNTHETIC BIOCONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOCONJUGATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOCONJUGATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOCONJUGATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOCONJUGATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOCONJUGATION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOCONJUGATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOCONJUGATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOCONJUGATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOCONJUGATION MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOCONJUGATION MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOCONJUGATION MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOCONJUGATION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOCONJUGATION MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOCONJUGATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOCONJUGATION MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOCONJUGATION MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOCONJUGATION MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES BIOCONJUGATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 126. CANADA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 127. CANADA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 128. CANADA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 129. CANADA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 130. CANADA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 131. CANADA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. CANADA BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. CANADA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 136. CANADA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 137. CANADA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 138. CANADA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 139. MEXICO BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 144. MEXICO BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 145. MEXICO BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 146. MEXICO BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 147. MEXICO BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. MEXICO BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. MEXICO BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BIOCONJUGATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 231. GERMANY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 236. GERMANY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 237. GERMANY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 238. GERMANY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 239. GERMANY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 240. GERMANY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 241. GERMANY BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 242. GERMANY BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 243. GERMANY BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. GERMANY BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. GERMANY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 246. GERMANY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 247. GERMANY BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 248. GERMANY BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 249. FRANCE BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 254. FRANCE BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 255. FRANCE BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 256. FRANCE BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 257. FRANCE BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 258. FRANCE BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 259. FRANCE BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 260. FRANCE BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 261. FRANCE BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. FRANCE BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. FRANCE BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 264. FRANCE BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 265. FRANCE BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 266. FRANCE BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 285. ITALY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 288. ITALY BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 289. ITALY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 290. ITALY BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 291. ITALY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 292. ITALY BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 293. ITALY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 294. ITALY BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 295. ITALY BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 296. ITALY BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 297. ITALY BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. ITALY BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. ITALY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 300. ITALY BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 301. ITALY BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 302. ITALY BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 303. SPAIN BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 304. SPAIN BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 305. SPAIN BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 308. SPAIN BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 309. SPAIN BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 310. SPAIN BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 311. SPAIN BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 312. SPAIN BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 313. SPAIN BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 314. SPAIN BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 315. SPAIN BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 316. SPAIN BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 317. SPAIN BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 318. SPAIN BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 319. SPAIN BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 320. SPAIN BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2025-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES BIOCONJUGATION MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2018-2024 (USD MILLION)
TABLE 340. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY BIOCONJUGATION TYPE, 2025-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2018-2024 (USD MILLION)
TABLE 342. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY OLIGONUCLEOTIDE BIOCONJUGATION, 2025-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 344. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
TABLE 346. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY SERVICES, 2025-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2018-2024 (USD MILLION)
TABLE 348. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY TECHNIQUE, 2025-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 350. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA BIOCONJUGATION MARKET SIZE, BY APPLICATIONS, 2018-2024 (USD MILLION)
TABLE 354. SAUDI ARABIA BIOCONJUGA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioconjugation market report include:
  • AbbVie Inc.
  • Abcam plc by Danaher Corporation
  • Abzena Limited
  • Agilent Technologies, Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bio-Techne Corporation
  • Biocon Limited
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Charles River Laboratories International, Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Innovagen AB
  • Johnson & Johnson Services Inc
  • Lonza Group AG
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi S.A.
  • Sartorius AG
  • Sorrento Therapeutics, Inc.
  • Sutro Biopharma, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.87 Billion
Compound Annual Growth Rate12.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Antibody-oligonucleotide Conjugates Market by Oligonucleotide Type, Conjugation Methodology, Targeting Strategy, Application, End-User - Global Forecast 2025-2030 - Product Image

Antibody-oligonucleotide Conjugates Market by Oligonucleotide Type, Conjugation Methodology, Targeting Strategy, Application, End-User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Peptide Antibody Conjugate Market by Linker Type (Cleavable, Non Cleavable), Therapeutic Area (Cardiovascular, Infectious Diseases, Oncology), End User, Peptide Type, Route of Administration, Conjugation Technology - Global Forecast 2025-2030 - Product Image

Peptide Antibody Conjugate Market by Linker Type (Cleavable, Non Cleavable), Therapeutic Area (Cardiovascular, Infectious Diseases, Oncology), End User, Peptide Type, Route of Administration, Conjugation Technology - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

DNA Microarray Market Size, Share & Trends Analysis Report By Type (Complementary DNA Microarrays, Oligonucleotide DNA Microarrays), By Application (Gene Expression Analysis, Genotyping), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report by Products & Services, Application (Biologics, Oligonucleotide Derived Drugs & Molecules), Region, with Growth Forecasts, 2025-2030 - Product Image

Large Molecule Bioanalytical Technologies Market Size, Share & Trends Analysis Report by Products & Services, Application (Biologics, Oligonucleotide Derived Drugs & Molecules), Region, with Growth Forecasts, 2025-2030

  • Report
  • 258 Pages
  • Global
From
Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029 - Product Image

Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Sequencing, Bioinformatics), Applications (Drug Discovery, Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental) - Global Forecast to 2029

  • Report
  • 537 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.